Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1994 Jan;32(1):246–248. doi: 10.1128/jcm.32.1.246-248.1994

Nosocomial epiglottitis associated with penicillin- and cephalosporin-resistant Streptococcus pneumoniae bacteremia.

R S Daum 1, J P Nachman 1, C D Leitch 1, F C Tenover 1
PMCID: PMC263009  PMID: 8126192

Abstract

We cared for a 4-year-old male with nosocomially acquired epiglottitis caused by Streptococcus pneumoniae. He had been receiving ceftazidime therapy when this infection was recognized. The S. pneumoniae isolate was of serotype 15B and was resistant to beta-lactam antibiotics, cephalosporins (including those with extended spectra), and trimethoprim-sulfamethoxazole. Clinicians and clinical microbiologists must be aware that cephalosporin susceptibility may no longer be assumed for penicillin-resistant S. pneumoniae isolates and that susceptibility testing for the extended-spectrum cephalosporins should be performed whenever this species is isolated from a normally sterile body fluid.

Full text

PDF
246

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appelbaum P. C. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis. 1992 Jul;15(1):77–83. doi: 10.1093/clinids/15.1.77. [DOI] [PubMed] [Google Scholar]
  2. BERENBERG W., KEVY S. Acute epiglottitis in childhood; a serious emergency, readily recognized at the bedside. N Engl J Med. 1958 May 1;258(18):870–874. doi: 10.1056/NEJM195805012581802. [DOI] [PubMed] [Google Scholar]
  3. Carroll K., Cohen S., Saxon B., Hamilton L. Failure of Micro Media FOX Microdilution System to detect decreased susceptibility of Streptococcus pneumoniae to penicillin. J Clin Microbiol. 1991 Nov;29(11):2651–2652. doi: 10.1128/jcm.29.11.2651-2652.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Faden H. S. Treatment of Haemophilus influenzae type B epiglottitis. Pediatrics. 1979 Mar;63(3):402–407. [PubMed] [Google Scholar]
  5. Figueiredo A. M., Connor J. D., Severin A., Vaz Pato M. V., Tomasz A. A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone. Antimicrob Agents Chemother. 1992 Apr;36(4):886–889. doi: 10.1128/aac.36.4.886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Friedland I. R., Shelton S., Paris M., Rinderknecht S., Ehrett S., Krisher K., McCracken G. H., Jr Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J. 1993 Mar;12(3):196–200. doi: 10.1097/00006454-199303000-00004. [DOI] [PubMed] [Google Scholar]
  7. Kramer B. S., Ramphal R., Rand K. H. Randomized comparison between two ceftazidime-containing regimens and cephalothin-gentamicin-carbenicillin in febrile granulocytopenic cancer patients. Antimicrob Agents Chemother. 1986 Jul;30(1):64–68. doi: 10.1128/aac.30.1.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Norrby S. R. Role of cephalosporins in the treatment of bacterial meningitis in adults. Overview with special emphasis on ceftazidime. Am J Med. 1985 Aug 9;79(2A):56–61. doi: 10.1016/0002-9343(85)90262-1. [DOI] [PubMed] [Google Scholar]
  9. Pizzo P. A., Hathorn J. W., Hiemenz J., Browne M., Commers J., Cotton D., Gress J., Longo D., Marshall D., McKnight J. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med. 1986 Aug 28;315(9):552–558. doi: 10.1056/NEJM198608283150905. [DOI] [PubMed] [Google Scholar]
  10. Reeves D. S., Bywater M. J., Holt H. A. The activity of cefpirome and ten other antibacterial agents against 2858 clinical isolates collected from 20 centres. J Antimicrob Chemother. 1993 Mar;31(3):345–362. doi: 10.1093/jac/31.3.345. [DOI] [PubMed] [Google Scholar]
  11. Rodriguez W. J., Khan W. N., Gold B., Feris J., Puig J., Sturla C. Ceftazidime in the treatment of meningitis in infants and children over one month of age. Am J Med. 1985 Aug 9;79(2A):52–55. doi: 10.1016/0002-9343(85)90261-x. [DOI] [PubMed] [Google Scholar]
  12. Rolston K. V., Nguyen H. T., Ho D. H., LeBlanc B., Bodey G. P. In vitro activity of Ro 23-9424, a dual-action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agents. Antimicrob Agents Chemother. 1992 Apr;36(4):879–882. doi: 10.1128/aac.36.4.879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rotimi V. O., Turk D. C. Transferable multiple antibiotic resistance in Haemophilus influenzae. J Antimicrob Chemother. 1981 Sep;8(3):187–192. doi: 10.1093/jac/8.3.187. [DOI] [PubMed] [Google Scholar]
  14. Shanholtzer C. J., Peterson L. R. False susceptible penicillin G MICs for Streptococcus pneumoniae with a commercial microdilution system. Am J Clin Pathol. 1986 May;85(5):626–629. doi: 10.1093/ajcp/85.5.626. [DOI] [PubMed] [Google Scholar]
  15. Sloas M. M., Barrett F. F., Chesney P. J., English B. K., Hill B. C., Tenover F. C., Leggiadro R. J. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J. 1992 Aug;11(8):662–666. [PubMed] [Google Scholar]
  16. Tweardy D. J., Jacobs M. R., Speck W. T. Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis. J Antimicrob Chemother. 1983 Aug;12(2):133–139. doi: 10.1093/jac/12.2.133. [DOI] [PubMed] [Google Scholar]
  17. Viladrich P. F., Gudiol F., Liñares J., Rufi G., Ariza J., Pallares R. Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. Am J Med. 1988 May;84(5):839–846. doi: 10.1016/0002-9343(88)90061-7. [DOI] [PubMed] [Google Scholar]
  18. Weingarten R. D., Markiewicz Z., Gilbert D. N. Meningitis due to penicillin-resistant Streptococcus pneumoniae in adults. Rev Infect Dis. 1990 Jan-Feb;12(1):118–124. doi: 10.1093/clinids/12.1.118. [DOI] [PubMed] [Google Scholar]
  19. Wiebe V. J., Smith B. R., DeGregorio M. W., Rappeport J. M. Pharmacology of agents used in bone marrow transplant conditioning regimens. Crit Rev Oncol Hematol. 1992 Nov;13(3):241–270. doi: 10.1016/1040-8428(92)90092-5. [DOI] [PubMed] [Google Scholar]
  20. Young L. S. Empirical antimicrobial therapy in the neutropenic host. N Engl J Med. 1986 Aug 28;315(9):580–581. doi: 10.1056/NEJM198608283150910. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES